We report a new genetic multi-system disorder caused by mutations affecting inhibitory G-protein signaling. Whole exome sequencing of 9 individuals from 6 unrelated families, from 4 different continents, with overlapping clinical manifestations identified bi-allelic loss-of-function and missense variants in GNB5 that encodes the G-protein β subunit 5. This autosomal recessive disease combines the very unique finding of early-onset Heart rate disturbance, as well as Eye disease, Intellectual disability, Gastric problems, HypoTonia and Seizures; thus we propose the acronym HEIGHTS. A striking association between the nature of the variants and clinical severity of the syndrome was observed: individuals with loss-of-function alleles had more severe symptoms, including significant developmental delay, speech defects, severe hypotonia, pathological gastro-esophageal reflux, retinal disease and sinus node dysfunction, whereas carriers of a homozygous missense variant presented with a clinically milder phenotype. Zebrafish knocked out for gnb5 faithfully recapitulated the phenotypic spectrum of affected individuals, including cardiac, neurological and ophthalmological abnormalities, thus providing further experimental evidence for a direct role of GNB5 in the control of heart rate, hypotonia, and vision.
Main text
Heterotrimeric G proteins trigger a signal transduction cascade composed of α, β, and γ subunits. They are associated with G protein-coupled receptors (GPCRs) in modulating an array of cellular functions, including release of a multitude of hormones and growth factors, regulation of cell contraction and migration, as well as cell growth and differentiation during development 1-3 4 .
G-protein coupled signaling plays a crucial role in neuronal communication, including regulation of the antagonistic effects of the parasympathetic and sympathetic branches of the autonomic nervous system throughout the body.
We report a new genetic disorder caused by mutations affecting GNB5 (MIM: 604447), encoding guanine nucleotide binding protein, subunit beta 5, with disease manifestation in multiple systems.
We identified nine affected individuals (six females and three males) from six Table 1 , Supplemental text). We suggest describing this syndrome, and aggregate of rare endophenotypes, associated with pathogenic variation in the same gene, with the acronym "HEIGHTS" (Heart and Eye disease, Intellectual disability, Gastric problems, HypoTonia and Seizures).
As no potentially pathogenic genomic structural abnormalities were identified by array-CGH and karyotyping of the affected subjects, we applied whole exome sequencing (WES) to all the affected individuals and their healthy parents. Families were recruited in Italy (family A), Brazil (B and F), the United States of America (C and D) and the Netherlands (E). The institutional review boards of the IRCCS Casa Sollievo Della Sofferenza Hospital, the "Hospital das Clínicas da Universidade de São Paulo", the Baylor College of Medicine, the Amsterdam Academic Medical Center and the University of Lausanne approved this study. Participants were enrolled after written informed consent was obtained from parents or legal guardians. The clinical evaluation included medical history interviews, a physical examination and review of medical records. To uncover genetic variants associated with the complex phenotype shown by the nine affected subjects we sequenced their exomes and that of their parents. DNA libraries were prepared from bloodderived genomic DNAs by standard procedures. Exomes were captured and sequenced using different platforms to reach 50-120-fold coverage on average (Supplemental text). Variants were called as previously described [5] [6] [7] . Variants were filtered based on inheritance patterns including autosomal recessive, X-linked and de novo/autosomal dominant. Variants with MAF<0.05% in control cohorts (dbSNP, the 1000 genome project, NHLBI GO Exome Sequencing Project, the Exome Aggregation Consortium database and our in-house databases) and predicted to be deleterious by SIFT 8 , PolyPhen-2 9 and/or UMD predictor 10 were prioritized.
As some families reported a potential history of consanguinity (family B, C and F, Figure 1 ; Table 1 ) we filtered variants using Mendelian expectations for the assumption of a rare autosomal recessive trait. We found only the GNB5 gene compliant with Mendelian expectations and bearing bi-allelic putative deleterious variants in all affected individuals (Figure 1, Table S1 ). Sanger sequencing in each family confirmed the anticipated segregation of the GNB5 variants. Strikingly, the variants found in the severely affected individuals 
Supplemental text).
In line with the clinical presentation of HEIGHTS syndrome, Gnb5 ablation in mice resulted in marked neurobehavioral abnormalities, including learning deficiencies, hyperactivity, impaired gross motor coordination, abnormal gait 12 , defective visual adaptation 13 and perturbed development and functioning of retinal bipolar cells 14 . Correspondingly, mice lacking Rgs6, the GNB5-dependent RGS protein enriched in heart tissue, exhibit bradycardia and hypersensitivity to parasympathomimetics 15; 16 . To independently investigate the functional effects of HEIGHTS-associated variation of GNB5 in the full phenotypic spectrum of subjects reported herein, we engineered a zebrafish model knocked out for gnb5.
CRISPR/Cas9 genome editing was used to generate zebrafish with LoF mutations in gnb5a and gnb5b, the two GNB5 paralogs present in the genome of this teleost ( Figure S5 ). We identified stable lines with a +7bp insertion in gnb5a and a -8bp +15bp deletion/insertion in gnb5b causing a frameshift and premature truncation of the encoded proteins, respectively ( Figure S6 ). It was anticipated that gnb5a and gnb5b might have redundant functions, which was confirmed by the absence of overt phenotypes in embryos homozygous for either LoF mutations. In-crosses of gnb5a/gnb5b double heterozygous carriers resulted in clutches of embryos containing the expected 6.25% of
gnb5a -/-/gnb5b -/-double mutants (henceforth referred to as gnb5 mutants).
Consistent with HEIGHTS syndrome manifestations, zebrafish mutants have no striking dysmorphologic features ( Figure S6d ), but the larvae generally die 7-14 days post fertilization (dpf).
To assess the putative involvement of GNB5 in autonomic nervous system functions, we investigated the GNB5/RGS/GIRK channel pathway. As GNB5 recruits RGS proteins to G-protein-coupled inward rectifier potassium (GIRK) channels involved in the hyperpolarization of cell membranes 16; 17 , we first investigated if LoF of GNB5 could delay GIRK channel deactivation kinetics, increase hyperpolarization time of cell membranes, and impair cell responsiveness to new stimuli. Carbachol is a parasympathomimetic compound that activates acetylcholine receptors of the heart (NCBI, PubChem) and the GNB5/RGS/GIRK channel pathway. Treatment of gnb5 mutant larvae with carbachol resulted in a strong decrease of the heart rate, whereas it had little effect on wild-type and sibling larvae (Figure 3) , consistent with loss of negative regulation of the cardiac GIRK channel by GNB5/RGS. In contrast, treatment with the sympathetic agonist isoproterenol resulted in an increased heart rate that was similar in wild-type, sibling and gnb5 mutant larvae (Figure 3) . These results indicate that GNB5 is crucial for the parasympathetic control of heart rate, but not for sympathetic control suggesting that lack of GNB5 is associated with extreme bradycardia at rest. Correspondingly, HEIGHTS individuals present severe bradycardia at rest (minimal observed heart rates of <25bpm (beats per minute)) combined with a normal chronotropic response (max heart rates >150 bpm).
The severe muscle hypotonia reported in HEIGHTS individuals could result from GIRK-mediated hyperpolarization of neurons controlling skeletal muscle tone. gnb5 mutant embryos hatched normally from their chorion, a process that requires muscle contraction, but their swimming behavior appeared abnormal at 3 dpf. To investigate whether this abnormal behavior was linked to neurologic dysfunction and hypotonia, we examined the touch-evoked escape response. We anticipated that neurons would only become fully hyperpolarized after an initial stimulus and thus presented the embryos with three consecutive tactile stimuli. Whereas wild-type larvae rapidly swam away in response to repeated tactile stimuli, gnb5 mutants showed a significant decrease in swimming distance and swimming speed at stimulus two (P≤0.0001) and three (P≤0.01), but not after the first stimulus (Figure 4a-c) .
Accordingly, gnb5 mutant larvae were predominantly unresponsive to repeated tactile stimuli (Supplemental movies). To test whether this abnormal escape response is the consequence of neurologic dysfunction rather than reduced muscle function, we performed a tail movement assay. 5 dpf larvae were given a strong tactile stimulus while recording the movement of the tail (Figure 4d-e) . No significant difference was detected in the maximum tail angle between wild-type and gnb5 mutant larvae (Figure 4e) .
These results indicate that the tail muscles of gnb5 mutants are fully functional and that the abnormal escape response is associated with neurological dysfunction and possibly muscle hypotonia.
Since HEIGHTS individuals have visual problems, including nystagmus, we investigated the visual system by measuring the optokinetic response (OKR) of gnb5 mutant larvae. When wild-type larvae were placed in a drum with rotating light stimulus (Figure S7a) , the OKR consists of smooth pursuit eye movements followed by rapid rest saccades in the opposite direction ( Figure   S7b , Supplemental movies). In contrast, OKR was completely absent in gnb5 mutant larvae although their eyes showed no morphological abnormalities and could make eye movements ( Figure S7c, Supplemental   movies) . This indicates that the eye muscles are functional in gnb5 mutants but that proper eye-movement control depends on GNB5. Overall these data showed that gnb5 mutants faithfully recapitulate the phenotypic spectrum of HEIGHTS patients, including cardiac, neurologic and ophthalmologic abnormalities.
These results for the first time provide evidence for a direct role of GNB5 in the control of heart rate, motor capacity, and vision. Whereas the Gβ1-4 are highly homologous and widely expressed 18 , Gβ5 exhibits much less homology with the other isoforms and is preferentially expressed in the brain and nervous system 19; 20 .
Germline de novo GNB1 variants cause severe neurodevelopmental disability 21 , hypotonia and seizures. GNB3 bi-allelic LoF has been linked to stationary night blindness in human 22 , retinal degeneration in chicken 23 and reduced cone sensitivity and mild bradycardia in mice 24; 25 . A single nucleotide polymorphism (SNP) in GNB3 was associated with postural tachycardia syndrome 26 , incidence of cardiovascular disease and stroke 27 . Similarly, GNB2 and GNB4 map to loci governing heart rate on chromosome 7 and 3, respectively 28; 29 . We hereby demonstrate that bi-allelic LoF and missense variants in GNB5 cause the multisystem HEIGHTS syndrome with features that include global developmental delay, sinus node dysfunction, seizures, eye abnormalities, gastric problems and generalized hypotonia. We highlight the importance of GNB5 for neuronal signaling, including the regulation of the antagonistic effects of the parasympathetic and sympathetic nervous system. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Ablation of the GNB3 gene in mice does not affect body weight, metabolism or blood pressure, but causes bradycardia. Cellular signalling 26, 2514-2520. 26. Nakao, R., Tanaka, H., Takitani, K., Kajiura, M., Okamoto, N., Kanbara, Y., and Tamai Complete pedigree charts, consanguinity status, variants, and related homozygous and/or compound heterozygous alleles are reported in Figure 1 and 
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